-
Loading metrics
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study
- Øystein Fluge,
- Ove Bruland,
- Kristin Risa,
- Anette Storstein,
- Einar K. Kristoffersen,
- Dipak Sapkota,
- Halvor Næss,
- Olav Dahl,
- Harald Nyland,
- Olav Mella
x
- Published: October 19, 2011
- https://doi.org/10.1371/journal.pone.0026358
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved